GENTARGET INC.

Company Overview

Founded in 2008, GenTarget provides proprietary bioreagents and services with an emphasis on lentivirus and adenovirus gene delivery technologies, providing pre-made lentiviruses and adenovirus or gene over-expression, knockdown, miRNA expression, pre-made mammalian stable cell lines, and more.

The company has developed proprietary technologies such as the SureTiter Lentiviral system, LocLightLive cell imaging, LoxP GFP/RFP ColorSwitch for CRE reporting system, and the Eco instant PCR cloning method, as well as the Signal Transduction Pathway Report Lentivirus product series. The company offers iPSC lentiviral particles utilizing either the super cytomegalovirus or EF1α promoters expressing individual iPSC factors, as well as particles expressing all four factors chained under an inducible promoter.

Company's Business Segments

• Lentivirus products : Premade Lentivirus, Microrna Lentivirus, Anti Mirna Lentivirus, shRNA lentivirus, Pathway Reporter, Cell Immortalization and many others.